Windtree Therapeutics Stock In The News
| WINT Stock | USD 3.68 0.09 2.39% |
Our overall analysis of Windtree Therapeutics' news coverage and content from conventional and social sources shows investors' bearish mood towards Windtree Therapeutics. The specific impact of Windtree Therapeutics news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Windtree Therapeutics' overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Windtree Therapeutics headlines in addition to utilizing other, more conventional financial analysis modules. Check out Windtree Therapeutics Backtesting and Windtree Therapeutics Hype Analysis. For more information on how to buy Windtree Stock please use our How to Invest in Windtree Therapeutics guide.
Windtree |
Windtree Therapeutics Today Top News and Investor Outlook
Windtree Therapeutics Past News Timeline
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Windtree and other traded companies coverage with news coverage. We help investors stay connected with Windtree headlines for the 26th of February to make an informed investment decision based on correlating the impacts of news items on Windtree Stock performance. Please note that trading solely based on the Windtree Therapeutics hype is not for everyone as timely availability and quick action are needed to avoid losses.
Windtree Therapeutics stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Windtree earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Windtree Therapeutics that are available to investors today. That information is available publicly through Windtree media outlets and privately through word of mouth or via Windtree internal channels. However, regardless of the origin, that massive amount of Windtree data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Windtree Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Windtree Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Windtree Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Windtree Therapeutics alpha.
Windtree Largest EPS Surprises
Earnings surprises can significantly impact Windtree Therapeutics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-05-15 | 2024-03-31 | -0.94 | -0.74 | 0.2 | 21 | ||
2024-03-29 | 2023-12-31 | -0.94 | -0.74 | 0.2 | 21 | ||
2023-11-09 | 2023-09-30 | -0.63 | -0.86 | -0.23 | 36 | ||
2023-08-07 | 2023-06-30 | -0.68 | -1.64 | -0.96 | 141 | ||
2022-08-11 | 2022-06-30 | -9 | -10.0 | -1.0 | 11 | ||
2020-11-16 | 2020-09-30 | -24.25 | -27.0 | -2.75 | 11 |
Windtree Therapeutics Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Windtree Therapeutics Stock. The global stock market is bearish. About 62% of major world exchanges and indexes are down. See today's market update for more information.
19th of February 2025
Disposition of 334 shares by Craig Fraser of Windtree Therapeutics subject to Rule 16b-3 at MacroaxisInsider
14th of February 2025
Windtree Therapeutics files for secondary stock offering at seekingalpha.com
4th of February 2025
WINT appoints real estate veteran Michael Colacino as chairman of the board of directors at prnewswire.com
23rd of January 2025
Disposition of 275938 shares by Huang James of Windtree Therapeutics at 12.09 subject to R... at MacroaxisInsider
14th of January 2025
WINT and Ferguson announce strategic collaboration to elevate water management and leak mi... at prnewswire.com
8th of January 2025
Windtree Therapeutics Announces New Corporate Strategy Seeking to Identify and Acquire FDA... at globenewswire.com
11th of December 2024
Short Interest in Windtree Therapeutics, Inc. Increases By 389.6 at thelincolnianonline.com
5th of December 2024
Windtree Therapeutics faces Nasdaq delisting issues at investing.com
27th of November 2024
Windtree Therapeutics Reports Third Quarter 2024 Financial Results and Provides Key Busine... at news.google.com
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Windtree Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Windtree Therapeutics' short interest history, or implied volatility extrapolated from Windtree Therapeutics options trading.
Additional Tools for Windtree Stock Analysis
When running Windtree Therapeutics' price analysis, check to measure Windtree Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Windtree Therapeutics is operating at the current time. Most of Windtree Therapeutics' value examination focuses on studying past and present price action to predict the probability of Windtree Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Windtree Therapeutics' price. Additionally, you may evaluate how the addition of Windtree Therapeutics to your portfolios can decrease your overall portfolio volatility.